What is the share price of Tarsons Products Ltd (TARSONS) today?
The share price of TARSONS as on 24th July 2026 is ₹312.75. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Tarsons Products Ltd (TARSONS) share?
The past returns of Tarsons Products Ltd (TARSONS) share are- Past 1 week: 4.25%
- Past 1 month: 19.55%
- Past 3 months: 51.11%
- Past 6 months: 58.41%
- Past 1 year: -18.30%
- Past 3 years: -47.62%
- Past 5 years: -61.79%
What are the peers or stocks similar to Tarsons Products Ltd (TARSONS)?
The peers or stocks similar to Tarsons Products Ltd (TARSONS) include:What is the market cap of Tarsons Products Ltd (TARSONS) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Tarsons Products Ltd (TARSONS) is ₹1664.03 Cr as of 24th July 2026.What is the 52 week high and low of Tarsons Products Ltd (TARSONS) share?
The 52-week high of Tarsons Products Ltd (TARSONS) is ₹385.40 and the 52-week low is ₹164.45.What is the PE and PB ratio of Tarsons Products Ltd (TARSONS) stock?
The P/E (price-to-earnings) ratio of Tarsons Products Ltd (TARSONS) is 116.20. The P/B (price-to-book) ratio is 2.64.Which sector does Tarsons Products Ltd (TARSONS) belong to?
Tarsons Products Ltd (TARSONS) belongs to the Health Care sector & Health Care Equipment & Supplies sub-sector.How to buy Tarsons Products Ltd (TARSONS) shares?
You can directly buy Tarsons Products Ltd (TARSONS) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Tarsons Products Ltd
TARSONS Share Price
NSE₹312.751.20% (-3.80)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TARSONS Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
GoodThe stock is underpriced and is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
TARSONS Performance & Key Metrics
TARSONS Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 116.37 | 2.64 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.74 | 5.90 | 0.53% |
100%
Analysts have suggested that investors can buy this stock
from 1 analyst
Price Upside
Earnings Growth
Rev. Growth
TARSONS Company Profile
Tarsons Products Limited is engaged in the designing, development, manufacturing of a range of labware products which helps scientific discovery and healthcare
PE Ratio
40.91
40.91
1Y Return
9.51%
9.51%
Buy Reco %
87.50
87.50
POLYMED
PE Ratio
52.36
52.36
1Y Return
19.61%
19.61%
Buy Reco %
75.00
75.00
BOROSCI
PE Ratio
39.09
39.09
1Y Return
12.82%
12.82%
Buy Reco %
0.00
0.00
LAXMIDENTL
PE Ratio
41.06
41.06
1Y Return
52.94%
52.94%
Buy Reco %
100.00
100.00
ONEGLOBAL
PE Ratio
16.58
16.58
1Y Return
136.98%
136.98%
Buy Reco %
0.00
0.00
TARSONS Sentiment Analysis
TARSONS Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
TARSONS Stock Summary · June 2026
Strong top‑line outperformance was the dominant message, with consolidated Q4 revenue at INR 121 crore (up 7.4% YoY) that reinforced management’s view of gradual improvement and confidence in longer‑term growth. Management highlighted robust domestic demand—double‑digit quarterly domestic growth—while exports weakened amid Middle East geopolitics, higher freight and container shortages, and only a tentative easing of supply‑chain strains in recent weeks. They emphasized finishing a multi‑year capex program that will materially expand capacity and diversify products, alongside disciplined working‑capital management and a priority on deleveraging over the next 2–3 years. At the same time they acknowledged clear tension: a recent sharp spike in raw‑material costs has materially squeezed margins and limits the ability to fully pass on increases, so price moves have been selective and gradual. Reported FY‑end margins were healthy but management warned sustained inflation would compress them, while near term profitability is expected to remain moderate as new facilities ramp; capex completion in H1 FY27 and subsequent operating leverage are projected to drive cash flow for debt reduction.
TARSONS Stock Growth Drivers
TARSONS Stock Growth Drivers
8Record revenue growth and improving top-line momentum
Tarsons reported record quarterly and full‑year top‑line performance, with the company recording its highest-ever quarterly
Stronger cash profitability and operating cash flow
Underlying cash earnings and operating cash generation showed clear improvement: consolidated cash PAT for FY'26
TARSONS Stock Challenges
TARSONS Stock Challenges
6Export decline and intensifying international competitive pressure
Tarsons experienced a meaningful export setback in Q4 FY'26 with export revenue down about 13.4%
Raw‑material inflation and margin compression
A concentrated spike in input costs over the March–May period—management cites raw‑material increases of roughly
TARSONS Forecast
TARSONS Forecasts
Price
Revenue
Earnings
TARSONS Share Price Forecast
TARSONS Share Price Forecast
2026
Current
₹312.75
Baseline
Forecast for Apr 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹312.75
Baseline
Forecast for Apr 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
TARSONS Company Revenue Forecast
TARSONS Company Revenue Forecast
2026
Current
₹446.69
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2026
Current
₹446.69
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
TARSONS Stock EPS (Earnings Per Share) Forecast
TARSONS Stock EPS (Earnings Per Share) Forecast
2026
Current
₹2.69
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
2026
Current
₹2.69
Baseline
Forecast for Mar 2027
High
₹—
Median
₹—
Low
₹—
All values in ₹
TARSONS
TARSONS
Income
Balance Sheet
Cash Flow
Quarterly Normal View
TARSONS Income Statement
TARSONS Income Statement
Quarterly Normal View
| Quarter | dec 2023 | mar 2024 | jun 2024 | sep 2024 | dec 2024 | mar 2025 | jun 2025 | sep 2025 | dec 2025 | mar 2026 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 65.03 | 109.10 | 87.70 | 107.67 | 96.53 | 116.47 | 94.70 | 108.13 | 116.32 | 127.76 | ||||||||||
Operating & Other expenses | 38.90 | 75.47 | 66.04 | 73.94 | 66.04 | 75.67 | 66.66 | 74.89 | 77.73 | 86.66 | ||||||||||
EBITDA | 26.13 | 33.63 | 21.66 | 33.73 | 30.49 | 40.80 | 28.04 | 33.24 | 38.59 | 41.10 | ||||||||||
| Depreciation/Amortization | 10.06 | 12.33 | 11.03 | 14.03 | 17.41 | 20.03 | 19.94 | 22.48 | 25.04 | 29.08 | ||||||||||
| PBIT | 16.07 | 21.30 | 10.63 | 19.70 | 13.08 | 20.77 | 8.10 | 10.76 | 13.55 | 12.02 | ||||||||||
| Interest & Other Items | 2.51 | 4.25 | 4.32 | 4.84 | 5.03 | 5.20 | 5.07 | 5.18 | 6.05 | 6.25 | ||||||||||
| PBT | 13.56 | 17.05 | 6.31 | 14.86 | 8.05 | 15.57 | 3.03 | 5.58 | 7.50 | 5.77 | ||||||||||
| Taxes & Other Items | 3.62 | 6.73 | 2.30 | 4.58 | 2.79 | 5.37 | 1.25 | 2.27 | 2.47 | 1.59 | ||||||||||
| Net Income | 9.94 | 10.32 | 4.01 | 10.28 | 5.26 | 10.20 | 1.78 | 3.31 | 5.03 | 4.18 | ||||||||||
| EPS | 1.87 | 1.94 | 0.75 | 1.93 | 0.99 | 1.92 | 0.34 | 0.62 | 0.95 | 0.79 |
TARSONS Company Updates
FY 2026FY 2026
Investor Presentation
May 23PDF
Feb 6PDF
Nov 12PDF
Aug 12PDF
TARSONS Stock Peers
TARSONS Past Performance & Peer Comparison
TARSONS Past Performance & Peer Comparison
Comparing 3 stocks from
Health CareHealth Care Equipment & Supplies
Compare valuation on Screener
Health CareHealth Care Equipment & Supplies
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Tarsons Products Ltd | 116.20 | 2.64 | — |
| Inventurus Knowledge Solutions Ltd | 40.91 | 16.50 | — |
| Poly Medicure Ltd | 52.36 | 6.10 | 0.21% |
| Borosil Scientific Ltd | 39.09 | 3.34 | — |
TARSONS Stock Price Comparison
Compare TARSONS with any stock or ETFCompare TARSONS with any stock or ETF
TARSONS
TARSONS Holdings
TARSONS Shareholdings
TARSONS Promoter Holdings Trend
TARSONS Promoter Holdings Trend
TARSONS Institutional Holdings Trend
TARSONS Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TARSONS Shareholding Pattern
TARSONS Shareholding Pattern
TARSONS Shareholding History
TARSONS Shareholding History
Foreign Institutions
Mutual Funds Invested in TARSONS
Mutual Funds Invested in TARSONS
No mutual funds holding trends are available
Top 2 Mutual Funds holding Tarsons Products Ltd
| Funds (Top 2) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0003% | Percentage of the fund’s portfolio invested in the stock 0.03% | Change in the portfolio weight of the stock over the last 3 months 0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 119/130 (0) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.0000% | Percentage of the fund’s portfolio invested in the stock 0.00% | Change in the portfolio weight of the stock over the last 3 months -0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 924/1047 (0) |
Compare 3-month MF holding change on Screener
smallcases containing TARSONS stock
smallcases containing TARSONS stock
Looks like this stock is not in any smallcase yet.
TARSONS Events
TARSONS Events
TARSONS Dividend Trend
No dividend trend available
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TARSONS Dividend Trend
No dividend trend available
TARSONS Upcoming Dividends
TARSONS Upcoming Dividends
No upcoming dividends are available
TARSONS Past Dividends
TARSONS Past Dividends
Cash Dividend
Ex DateEx DateSep 20, 2024
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 20, 2024
TARSONS Stock News & Opinions
TARSONS Stock News & Opinions
Articles & Videos
Earnings
Earnings
Tarsons Products consolidated net profit declines 59.02% in the March 2026 quarterNet profit of Tarsons Products declined 59.02% to Rs 4.18 crore in the quarter ended March 2026 as against Rs 10.20 crore during the previous quarter ended March 2025. Sales rose 7.31% to Rs 120.93 crore in the quarter ended March 2026 as against Rs 112.69 crore during the previous quarter ended March 2025. For the full year,net profit declined 51.90% to Rs 14.32 crore in the year ended March 2026 as against Rs 29.77 crore during the previous year ended March 2025. Sales rose 7.67% to Rs 422.51 crore in the year ended March 2026 as against Rs 392.41 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales120.93112.69 7 422.51392.41 8 OPM %28.3432.85 -27.9128.22 - PBDT34.6335.60 -3 119.56107.30 11 PBT5.5515.57 -64 23.0344.80 -49 NP4.1810.20 -59 14.3229.77 -52 Powered by Capital Market - Live
2 months agoCapital Market - Live
Corporate
Corporate
Tarsons Products schedules board meetingTarsons Products will hold a meeting of the Board of Directors of the Company on 22 May 2026.
2 months agoCapital Market - Live
Corporate
Corporate
Board of Tarsons Products approves investment of EUR 3 million in Tarsons Life ScienceThe board of Tarsons Products at its meeting held on 06 February 2026 has approved equity infusion of further EUR 3 Million in its wholly-owned subsidiary, Tarsons Life Science, a company incorporated in Singapore for meeting its operational and financial expenses.Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Board of Tarsons Products approves change in directorateThe board of Tarsons Products at its meeting held on 06 February 2026 has approved the appointment of Vinesh Mohan Kriplani (DIN: 08212644) as an Additional Director (Category: Non-Executive Independent Director). The board also accepted the resignation of Girish Paman Vanvari (DIN:07376482) as an Independent Director of the Company. Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
Tarsons Products consolidated net profit declines 4.18% in the December 2025 quarterNet profit of Tarsons Products declined 4.18% to Rs 5.04 crore in the quarter ended December 2025 as against Rs 5.26 crore during the previous quarter ended December 2024. Sales rose 12.76% to Rs 107.89 crore in the quarter ended December 2025 as against Rs 95.68 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales107.8995.68 13 OPM %29.2130.97 - PBDT33.8925.46 33 PBT8.868.05 10 NP5.045.26 -4 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Corporate
Tarsons Products to conduct board meetingTarsons Products will hold a meeting of the Board of Directors of the Company on 6 February 2026.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Earnings
Tarsons Products consolidated net profit declines 67.74% in the September 2025 quarterNet profit of Tarsons Products declined 67.74% to Rs 3.32 crore in the quarter ended September 2025 as against Rs 10.29 crore during the previous quarter ended September 2024. Sales rose 3.10% to Rs 102.33 crore in the quarter ended September 2025 as against Rs 99.25 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales102.3399.25 3 OPM %26.8225.49 - PBDT28.0728.90 -3 PBT5.5914.87 -62 NP3.3210.29 -68 Powered by Capital Market - Live
8 months agoCapital Market - Live
Earnings
Earnings
Tarsons Products standalone net profit declines 49.50% in the September 2025 quarterNet profit of Tarsons Products declined 49.50% to Rs 6.53 crore in the quarter ended September 2025 as against Rs 12.93 crore during the previous quarter ended September 2024. Sales rose 0.49% to Rs 80.51 crore in the quarter ended September 2025 as against Rs 80.12 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales80.5180.12 0 OPM %32.4729.34 - PBDT29.0529.48 -1 PBT8.8817.52 -49 NP6.5312.93 -49 Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Tarsons Products announces board meeting dateTarsons Products will hold a meeting of the Board of Directors of the Company on 12 November 2025.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Corporate
Tarsons Products AGM scheduledTarsons Products announced that the 42th Annual General Meeting(AGM) of the company will be held on 22 September 2025.Powered by Capital Market - Live
11 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant